Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tung-Liang Lin

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Leukemia Research|October 16, 2012
Emerging kinetics of BCR-ABL1 mutations and their effect on disease outcomes in chronic myeloid leukemia patients with imatinib failureLee-Yung Shih, Ming-Chung Kuo, Ching-Yuan Kuo, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 31, 2022
Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup AnalysisKazutaka Sunami, Takashi Ikeda, Shang-Yi Huang, et al.
Virchows Archiv : an International Journal of Pathology|September 16, 2015
CD5 positivity is an independent adverse prognostic factor in elderly patients with diffuse large B cell lymphomaWen-Yu Chuang, Hung Chang, Lee-Yung Shih, et al.
Haematologica|September 3, 2013
Clonal leukemic evolution in myelodysplastic syndromes with TET2 and IDH1/2 mutationsTung-Liang Lin, Yasunobu Nagata, Hsiao-Wen Kao, et al.
Bone Marrow Transplantation|December 18, 2025
Impact of early failure of induction on transplant outcomes in Hodgkin lymphomaYu-Sung Chang, Wan-Chen Hsieh, Hsueh-Mei Chang, et al.
British Journal of Cancer|January 30, 2023
Children with chronic myeloid leukaemia treated with front-line imatinib have a slower molecular response and comparable survival compared with adults: a multicenter experience in TaiwanHsi-Che Liu, Ming-Chung Kuo, Kang-Hsi Wu, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 6, 2023
Bortezomib, Melphalan, and Prednisone With or Without Daratumumab in Transplant-ineligible Asian Patients With Newly Diagnosed Multiple Myeloma: The Phase 3 OCTANS StudyWeijun Fu, Soo-Mee Bang, Honghui Huang, et al.
British Journal of Haematology|September 10, 2025
Taiwan consensus on pulmonary chronic graft-versus-host disease: A joint statement from the Taiwan Society of Blood and Marrow Transplantation (TBMT) and Taiwan Society of Pulmonary and Critical Care Medicine (TSPCCM)Xavier Cheng-Hong Tsai, Zong-Han Yao, Shu-Wei Chou, et al.
Translational Oncology|September 15, 2023
Nasopharyngeal carcinoma patient-derived xenograft mouse models reveal potential drugs targeting cell cycle, mTOR, and autophagy pathwaysHsin-Pai Li, Chen-Yang Huang, Kar-Wai Lui, et al.
British Journal of Haematology|March 25, 2025
Frequency and prognostic value of unconventional genetic subtypes in paediatric and young adult B-cell precursor acute lymphoblastic leukaemia in TaiwanYing-Jung Huang, Hsi-Che Liu, Ming-Chung Kuo, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Leukemia Research|October 16, 2012
Emerging kinetics of BCR-ABL1 mutations and their effect on disease outcomes in chronic myeloid leukemia patients with imatinib failureLee-Yung Shih, Ming-Chung Kuo, Ching-Yuan Kuo, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 31, 2022
Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup AnalysisKazutaka Sunami, Takashi Ikeda, Shang-Yi Huang, et al.
Virchows Archiv : an International Journal of Pathology|September 16, 2015
CD5 positivity is an independent adverse prognostic factor in elderly patients with diffuse large B cell lymphomaWen-Yu Chuang, Hung Chang, Lee-Yung Shih, et al.
Haematologica|September 3, 2013
Clonal leukemic evolution in myelodysplastic syndromes with TET2 and IDH1/2 mutationsTung-Liang Lin, Yasunobu Nagata, Hsiao-Wen Kao, et al.
Bone Marrow Transplantation|December 18, 2025
Impact of early failure of induction on transplant outcomes in Hodgkin lymphomaYu-Sung Chang, Wan-Chen Hsieh, Hsueh-Mei Chang, et al.
British Journal of Cancer|January 30, 2023
Children with chronic myeloid leukaemia treated with front-line imatinib have a slower molecular response and comparable survival compared with adults: a multicenter experience in TaiwanHsi-Che Liu, Ming-Chung Kuo, Kang-Hsi Wu, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 6, 2023
Bortezomib, Melphalan, and Prednisone With or Without Daratumumab in Transplant-ineligible Asian Patients With Newly Diagnosed Multiple Myeloma: The Phase 3 OCTANS StudyWeijun Fu, Soo-Mee Bang, Honghui Huang, et al.
British Journal of Haematology|September 10, 2025
Taiwan consensus on pulmonary chronic graft-versus-host disease: A joint statement from the Taiwan Society of Blood and Marrow Transplantation (TBMT) and Taiwan Society of Pulmonary and Critical Care Medicine (TSPCCM)Xavier Cheng-Hong Tsai, Zong-Han Yao, Shu-Wei Chou, et al.
Translational Oncology|September 15, 2023
Nasopharyngeal carcinoma patient-derived xenograft mouse models reveal potential drugs targeting cell cycle, mTOR, and autophagy pathwaysHsin-Pai Li, Chen-Yang Huang, Kar-Wai Lui, et al.
British Journal of Haematology|March 25, 2025
Frequency and prognostic value of unconventional genetic subtypes in paediatric and young adult B-cell precursor acute lymphoblastic leukaemia in TaiwanYing-Jung Huang, Hsi-Che Liu, Ming-Chung Kuo, et al.
Pageof 9